PROC (Procaps Group) Return on Gross Profit

PROC (Procaps Group Corp) - company brandmark

Procaps Group S.A. is focusing on organic growth and auditing, having temporarily stepped away from mergers. Business efficiency relies on maximizing CDMO capacity utilization to reduce unit costs. Dependence on polymer prices and capsule demand determines the current gross margin, where 0.00 expresses today's metric value, visualizing the company's manufacturing profitability.

Procaps Group Corp (PROC) Gross Profitability: for the period 07/04/2022 - 02/16/2025

Comprehensive metric breakdowns and analytics for Procaps Group S.A. (PROC)

- stock value and consensus price forecast:
- business market valuation indicators:
Fundamental valuation:PROC (Procaps Group)
Mass-produced product of Procaps Group Corp

Gross margin is calculated as the ratio of the difference between revenue and direct cost of goods sold to total sales. This indicator determines the efficiency of production processes and the business's ability to retain a share of profit before deducting operating expenses. Given the debt load of the Latin American assets of Procaps Group S.A. (PROC), the gross margin trend becomes a critical tool for monitoring pressure on production profitability.

Main competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Return on Gross Profit|Gross Profit Margin Tectonic Therapeutic|TNXP: Gross Margin|SXT China (SXTC) - Gross Margin|Gross Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Return on Sales by Gross Profit|Gross Profitability Invizyne (EXOZ)|ORMP - Gross Profit Margin|Gross Margin ENTX (Entera Bio)|Gross Sales Margin MindWalk Therapeutics|ABVC: Return on Gross Profit|CPIX - Gross Margin|QNTM (Quantum BioPharma) - Return on Gross Profit|Gross Profitability Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Gross Margin|Gross Margin ranitherapeutics.com|Gross Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Gross Return on Sales|lexariabioscience.com - Return on Gross Profit|Gross Margin Pulmatrix Inc PULM|Pheton Holdings - Gross Margin|Gross Profitability Margin APM|Lyra Therapeutics, Inc. (LYRA) - Gross Profitability|Gross Profit Margin Impact BioMedical, Inc. (IBO)|Gross Profitability TNF Pharma|YCBD: Gross Profit Rate|Gross Margin PRFX|CYTO - Gross Profit Margin|Gross Profitability Lipella LIPO|Gross Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin